Literature DB >> 17979705

Viral origins of human cancer.

E Boccardo1, L L Villa.   

Abstract

The first consistent observations that viruses could be associated with some types of cancer where made almost a century ago. Since then researchers have spent a great deal of effort to address the infectious origins of human cancer. As a result of these studies, a strong link between some viral agents and several human cancers has been established. Some viruses as the Epstein-Barr virus (EBV), hepatitis B virus (HBV), hepatitis C virus (HCV), human T-cell lymphotropic virus type I (HTLV-I), immunodeficiency virus type I (HIV-I) and several human papillomavirus types (including types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 66) have been classified as group 1 carcinogens by the International Agency for Research in Cancer (IARC). Infection by these viruses constitutes a heavy burden for human populations as it accounts for almost 15% of all human malignancies. Furthermore, many other viral agents have been classified as possibly carcinogenic to humans and others have been occasionally found in human tumors suggesting that this figure may be an underestimation of virus involvement in the etiology of human cancer. Therefore, viral infection appears as one of the main preventable cancer risk factors. We summarize the current state of knowledge concerning virus-induced/associated cancers and discuss its significance in the context of human carcinogenesis. Prevention and control of infection by these agents could dramatically reduce the incidence of some prevalent cancers and, consequently, have a great impact on public health.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17979705     DOI: 10.2174/092986707782023316

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  9 in total

1.  Virus proteins similar to human proteins as possible disturbance on human pathways.

Authors:  Zhao Jin; Masaaki Kotera; Susumu Goto
Journal:  Syst Synth Biol       Date:  2014-05-24

2.  Genetic analysis of cytomegalovirus in malignant gliomas.

Authors:  Bornali Bhattacharjee; Nicholas Renzette; Timothy F Kowalik
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

3.  The full-length isoform of human papillomavirus 16 E6 and its splice variant E6* bind to different sites on the procaspase 8 death effector domain.

Authors:  Sandy S Tungteakkhun; Maria Filippova; Nadja Fodor; Penelope J Duerksen-Hughes
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

4.  Human-derived IgG level as an indicator for EBV-associated lymphoma model in Hu-PBL/SCID chimeras.

Authors:  Yunlian Tang; Rongfang He; Yang Zhang; Fang Liu; Ailan Cheng; Yimou Wu; Runliang Gan
Journal:  Virol J       Date:  2011-05-09       Impact factor: 4.099

Review 5.  Bacterial immunotherapy of gastrointestinal tumors.

Authors:  Michael Linnebacher; Claudia Maletzki; Ulrike Klier; Ernst Klar
Journal:  Langenbecks Arch Surg       Date:  2011-12-22       Impact factor: 3.445

6.  The full recovery of mice (Mus Musculus C57BL/6 strain) from virus-induced sarcoma after treatment with a complex of DDMC delivery system and sncRNAs.

Authors:  Oxana V Klimenko; Alexey Sidorov
Journal:  Noncoding RNA Res       Date:  2019-03-30

Review 7.  Cancer Vaccines: Antigen Selection Strategy.

Authors:  Yue Zhao; Alexey V Baldin; Orkhan Isayev; Jens Werner; Andrey A Zamyatnin; Alexandr V Bazhin
Journal:  Vaccines (Basel)       Date:  2021-01-25

Review 8.  A Review of Cancer Genetics and Genomics Studies in Africa.

Authors:  Solomon O Rotimi; Oluwakemi A Rotimi; Bodour Salhia
Journal:  Front Oncol       Date:  2021-02-15       Impact factor: 5.738

Review 9.  Does the measles virus contribute to carcinogenesis? - a review.

Authors:  Daniel Benharroch; Jacob Gopas; Samuel Ariad
Journal:  J Cancer       Date:  2014-01-05       Impact factor: 4.207

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.